中山大学附属第一医院麻醉科,广东 广州 510080
戚智慧,硕士,研究方向:麻醉药物镇痛机制,E-mail:qizhh@mail2.sysu.edu.cn
纸质出版日期:2022-11-20,
收稿日期:2022-06-11,
扫 描 看 全 文
戚智慧,李静,王钟兴等.右美托咪定缓解三叉神经痛小鼠动态痛觉超敏反应[J].中山大学学报(医学科学版),2022,43(06):898-904.
QI Zhi-hui,LI Jing,WANG Zhong-xing,et al.Dexmedetomidine Attenuates Dynamic Allodynia in a Mouse Model of Trigeminal Neuropathic Pain[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(06):898-904.
戚智慧,李静,王钟兴等.右美托咪定缓解三叉神经痛小鼠动态痛觉超敏反应[J].中山大学学报(医学科学版),2022,43(06):898-904. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0605.
QI Zhi-hui,LI Jing,WANG Zhong-xing,et al.Dexmedetomidine Attenuates Dynamic Allodynia in a Mouse Model of Trigeminal Neuropathic Pain[J].Journal of Sun Yat-sen University(Medical Sciences),2022,43(06):898-904. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0605.
目的
2
初步探讨右美托咪定(DEX)对三叉神经痛小鼠动态痛觉超敏反应(DA)的镇痛作用及其机制。
方法
2
采用松散结扎法造成左侧三叉神经分支眶下神经(ION)慢性压缩性损伤(CCI)建立三叉神经痛病理模型。C57BL/6J小鼠随机进行如下分组:Sham(假手术)组,CCI-ION组、CCI-ION+vehicle(生理盐水注射)组,CCI-ION+DEX组、Sham+DEX组,每组4~6只实验动物。CCI-ION 7 d后,腹腔注射vehicle或DEX,并使用画刷轻触刺激的方式测定小鼠三叉神经分布区域(V2,V3区)的DA疼痛评分,免疫荧光染色检测三叉神经病理性疼痛后内侧前额叶皮层(mPFC)神经元激活情况,以及使用DEX后的镇痛效果。
结果
2
与Sham组相比,CCI-ION组小鼠在术后3 d或7 d可引起同侧和对侧V2、V3区域的DA反应(
P
=0.004 8;
P
<0.000 1),同时双侧大脑mPFC区域c-Fos(神经元兴奋性标记物)阳性神经元数量均显著上升(
P
=0.044 1;
P
=0.044 4)。与CCI-ION+vehicle组比较,15 μg/kg与30 μg/kg的DEX可缓解三叉神经病理性疼痛引起的双侧原发性和继发性反应(
P
<0.000 1),降低双侧mPFC脑区神经元的兴奋性(
P
=0.012 5;
P
=0.048 8),两个浓度的DEX镇痛效果并无明显差异(
P
>
0.05)。
结论
2
DEX可有效缓解CCI-ION后画刷轻触刺激诱导的双侧原发性和继发性DA反应,其作用可能是通过降低双侧mPFC脑区神经元的活性调控的。
Objective
2
To investigate the analgesic effect and mechanism of dexmedetomidine (DEX) on dynamic allodynia (DA) in mice with trigeminal neuropathic pain.
Methods
2
We established the model of trigeminal neuropathic pain in male mice by a chronic constriction injury (CCI) of the infraorbital branch of the trigeminal nerve (ION). Mice were randomly separated into the following groups: Sham, CCI-ION, CCI-ION+vehicle, CCI-ION+DEX, Sham+DEX (each group contained four to six mice). For the measurement of DA, the ipsilateral and contralateral skin of the whisker pad within the infraorbital territory (V2) or the lower jaw within the mandibular nerve territory (V3) were stimulated by light-moving brush strokes. We used immunofluorescence staining to evaluate the possible mechanisms.
Results
2
Compare with the sham group, light-moving brush strokes induced obvious DA in ipsilateral and contralateral skin of V2 territory and V3 territory at 3 d or 7 d after CCI-ION surgery (
P
=0.004 8;
P
<
0.000 1), and the number of c-Fos
(a marker for neuronal excitability) positive cells in bilateral mPFC increased significantly (
P
=0.044 1 ,
P
=0.044 4). In addition, 15 μg/kg and 30 μg/kg DEX separately alleviated bilateral primary and secondary DA induced by light-moving mechanical facial stimuli in mice with trigeminal neuropathic pain (
P
<
0.000 1), and decreased the excitability of neurons in bilateral mPFC (
P=
0.012 5,
P
=0.048 8). Furthermore, there was no significant difference in analgesic effect between the two concentrations of DEX (
P
>
0.05).
Conclusions
2
DEX is a useful therapeutic approach for attenuating DA in trigeminal neuropathic pain disorders. This effect is associated with the inhibition of hyperexcitability of neurons in mPFC induced by light-moving mechanical facial stimuli after trigeminal neuropathic pain.
右美托咪定前额叶皮层c-Fos神经病理性疼痛
dexmedetomidinemedial prefrontal cortexc-Fosneuropathic pain
Truini A, Garcia-Larrea L, Cruccu G. Reappraising neuropathic pain in humans-how symptoms help disclose mechanisms[J]. Nat Rev Neurol, 2013, 9(10): 572.
Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms[J]. Lancet Neurol, 2014, 13(9): 924-935.
Von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms[J]. Neuron, 2012, 73(4): 638-652.
Kaasa T, Romundstad L, Roald H, et al. Hyperesthesia one year after breast augmentation surgery increases the odds for persisting pain at four years a prospective four-year follow-up study[J]. Scand J Pain, 2010, 1(2): 75-81.
Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing[J]. Mol Neurobiol, 2019, 56(2): 1137-1166.
Apkarian AV, Bushnell MC, Treede RD, et al. Human brain mechanisms of pain perception and regulation in health and disease[J]. Eur J Pain, 2005, 9(4): 463-484.
Araya EI, Carvalho EC, Andreatini R, et al. Trigeminal neuropathic pain causes changes in affective processing of pain in rats[J]. Mol Pain, 2022, 18: 17448069211057750.
Deseure K, Hans GH. Chronic constriction injury of the rat's infraorbital nerve (IoN-CCI) to study trigeminal neuropathic pain[J]. J Vis Exp, 2015, (103): 53167.
Araya EI, Claudino RF, Piovesan EJ, et al. Trigeminal neuralgia: basic and clinical aspects[J]. Curr Neuropharmacol, 2020, 18(2): 109-119.
Davy A, Fessler J, Fischler M. Dexmedetomidine and general anesthesia: a narrative literature review of its major indications for use in adults undergoing non-cardiac surgery[J]. Minerva Anestesiol, 2017, 83(12): 1294-1308.
Kim YS, Chu Y, Han L, et al. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain[J]. Neuron, 2014, 81(4): 873-887.
Huang T, Li Y, Hu W, et al. Dexmedetomidine attenuates haemorrhage-induced thalamic pain by inhibiting the TLR4/NF-κB/ERK1/2 pathway in mice[J]. Inflammopharmacology, 2021, 29(6): 1751-1760.
Liang F, Liu M, Fu X, et al. Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation[J]. Saudi Pharm J, 2017, 25(4): 649-654.
Liu L, Ji F, Liang J, et al. Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury[J]. Brain Res, 2012, 1427: 1-9.
Yeo JH, Roh DH. Dexmedetomidine co-administered with lidocaine decreases nociceptive responses and trigeminal Fos expression without motor dysfunction and hypotension in a murine orofacial formalin model[J]. Life, 2022, 12(2): 215.
Bourane S, Duan B, Koch SC, et al. Gate control of mechanical itch by a subpopulation of spinal cord interneurons[J]. Science, 2015, 350(6260): 550-554.
Vos BP, Strassman AM, Maciewicz RJ. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve[J]. J Neurosci, 1994, 14(5): 2708-2723.
Landerholm ÅH, Hansson PT. Mechanisms of dynamic mechanical allodynia and dysesthesia in patients with peripheral and central neuropathic pain[J]. Eur J Pain, 2011, 15(5): 498-503.
Field MJ, Bramwell S, Hughes J, et al. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?[J]. Pain, 1999, 83(2): 303-311.
Hu TT, Wang RR, Tang YY, et al. TLR4 deficiency abrogated widespread tactile allodynia, but not widespread thermal hyperalgesia and trigeminal neuropathic pain after partial infraorbital nerve transection[J]. Pain, 2018, 159(2): 273-283.
Wu JR, Chen H, Yao YY, et al. Local injection to sciatic nerve of dexmedetomidine reduces pain behaviors, SGCs activation, NGF expression and sympathetic sprouting in CCI rats[J]. Brain Res Bull, 2017, 132: 118-128.
Zhao Y, He J, Yu N, et al. Mechanisms of dexmedetomidine in neuropathic pain[J]. Front Neurosci, 2020, 14: 330.
Wang Y, Shuai Y, Qiu F, et al. Dexmedetomidine-soaked nasal packing can reduce pain and improve sleep quality after nasal endoscopic surgery: a double-blind, randomized, controlled clinical trial[J]. Sleep Breath, 2021, 25(4): 2045-2052.
Kim NY, Kwon TD, Bai SJ, et al. Effects of dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia on pain attenuation after open gastrectomy in comparison with conventional thoracic epidural and fentanyl-based intravenous patient-controlled analgesia[J]. Int J Med Sci, 2017, 14(10): 951.
Lopez MM, Zech D, Linton JL, et al. Dexmedetomidine decreases postoperative pain and narcotic use in children undergoing alveolar bone graft surgery[J]. Cleft Palate Craniofac J, 2018, 55(5): 688-691.
Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia?[J]. Curr Opin Anesthesio, 2017, 30(4): 441-451.
Hoy SM, Keating GM. Dexmedetomidine[J]. Drugs, 2011, 71(11): 1481-1501.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构